A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 3
Status: | Recruiting |
---|---|
Conditions: | Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/8/2018 |
Start Date: | February 28, 2018 |
End Date: | September 2020 |
Contact: | Christine Chollack |
Email: | Christine.Chollack@nyumc.org |
Phone: | 646 754 4795 |
This is a 4-phase study to implement the NIDA CDEs in primary care settings. Collecting and
utilizing the CDEs in clinical practice requires a strategy for implementing screening to
collect substance use information that populates the CDEs, and assisting primary care medical
staff to offer appropriate interventions by providing clinical decision support (CDS) and a
mechanism for making referrals to addiction treatment. Investigators aim to maximize the
efficient adoption of screening, CDS, and treatment referrals by integrating all of these
activities into the electronic health record (EHR).
The study will be conducted at three sites, representing three large health systems. Each
phase will include deliverables essential to move to the next phase, and an independent
Advisory Committee will review progress and make recommendations at each transition about how
best to progress to each subsequent phase. Based on progress during earlier phases, the
Advisory Committee may recommend expansion to additional clinics or health systems during the
second part of Phase 4.
utilizing the CDEs in clinical practice requires a strategy for implementing screening to
collect substance use information that populates the CDEs, and assisting primary care medical
staff to offer appropriate interventions by providing clinical decision support (CDS) and a
mechanism for making referrals to addiction treatment. Investigators aim to maximize the
efficient adoption of screening, CDS, and treatment referrals by integrating all of these
activities into the electronic health record (EHR).
The study will be conducted at three sites, representing three large health systems. Each
phase will include deliverables essential to move to the next phase, and an independent
Advisory Committee will review progress and make recommendations at each transition about how
best to progress to each subsequent phase. Based on progress during earlier phases, the
Advisory Committee may recommend expansion to additional clinics or health systems during the
second part of Phase 4.
SPECIFIC AIMS
1. To program the NIDA CTN CDEs, the NIDA/ASAM electronic Clinical Quality Measure (eCQM),
and a lean decision support module into Epic.
2. To study the process of implementation of screening and referral using Epic-driven CDEs
and CDS in three primary care clinics / practices, including defining potential barriers
and facilitators to their adoption.
3. To evaluate the impact of implementation on:
- Patient level outcomes (diagnosis, treatment referral);
- Medical staff level outcomes (screening and assessment, clinical interventions
including counseling and treatment referral); and
- Systems level outcomes (logistics and costs of introducing the CDEs, feasibility).
1. To program the NIDA CTN CDEs, the NIDA/ASAM electronic Clinical Quality Measure (eCQM),
and a lean decision support module into Epic.
2. To study the process of implementation of screening and referral using Epic-driven CDEs
and CDS in three primary care clinics / practices, including defining potential barriers
and facilitators to their adoption.
3. To evaluate the impact of implementation on:
- Patient level outcomes (diagnosis, treatment referral);
- Medical staff level outcomes (screening and assessment, clinical interventions
including counseling and treatment referral); and
- Systems level outcomes (logistics and costs of introducing the CDEs, feasibility).
Inclusion Criteria:
- English speaking adult individuals age 18 years or older, and current employee or
patient at a Wave 1 clinic with direct patient contact.
Exclusion Criteria:
- Inability to provide informed consent.
We found this trial at
2
sites
Click here to add this to my saved trials
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai is...
Click here to add this to my saved trials